John A. Steinharter

6.1k total citations
30 papers, 778 citations indexed

About

John A. Steinharter is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, John A. Steinharter has authored 30 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in John A. Steinharter's work include Renal cell carcinoma treatment (18 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Bladder and Urothelial Cancer Treatments (7 papers). John A. Steinharter is often cited by papers focused on Renal cell carcinoma treatment (18 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Bladder and Urothelial Cancer Treatments (7 papers). John A. Steinharter collaborates with scholars based in United States, Canada and Denmark. John A. Steinharter's co-authors include Toni K. Choueiri, Lauren C. Harshman, Bradley A. McGregor, Dylan J. Martini, Aly‐Khan A. Lalani, Wanling Xie, Dominick Bossé, Xiao X. Wei, Eliezer M. Van Allen and Katherine M. Krajewski and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Cell and Annals of Oncology.

In The Last Decade

John A. Steinharter

28 papers receiving 772 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John A. Steinharter United States 13 541 431 231 161 134 30 778
Jae Young Joung South Korea 16 355 0.7× 589 1.4× 237 1.0× 186 1.2× 287 2.1× 83 929
Milena Perez Mak Brazil 12 399 0.7× 234 0.5× 189 0.8× 137 0.9× 107 0.8× 34 664
Huabin Hu China 14 491 0.9× 203 0.5× 156 0.7× 88 0.5× 171 1.3× 68 751
Melina E. Marmarelis United States 14 359 0.7× 312 0.7× 114 0.5× 98 0.6× 35 0.3× 61 590
R. Corre France 17 541 1.0× 816 1.9× 84 0.4× 113 0.7× 102 0.8× 88 1.0k
Julie Kobie United States 15 789 1.5× 647 1.5× 109 0.5× 176 1.1× 122 0.9× 27 967
Yasser Ged United States 12 212 0.4× 361 0.8× 244 1.1× 169 1.0× 87 0.6× 59 549
E. del Barco Spain 17 341 0.6× 260 0.6× 145 0.6× 118 0.7× 95 0.7× 66 629
Amaury Daste France 13 610 1.1× 279 0.6× 129 0.6× 47 0.3× 167 1.2× 66 848
Branka Čučević Croatia 7 840 1.6× 1.1k 2.4× 153 0.7× 120 0.7× 99 0.7× 16 1.2k

Countries citing papers authored by John A. Steinharter

Since Specialization
Citations

This map shows the geographic impact of John A. Steinharter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. Steinharter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. Steinharter more than expected).

Fields of papers citing papers by John A. Steinharter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. Steinharter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. Steinharter. The network helps show where John A. Steinharter may publish in the future.

Co-authorship network of co-authors of John A. Steinharter

This figure shows the co-authorship network connecting the top 25 collaborators of John A. Steinharter. A scholar is included among the top collaborators of John A. Steinharter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John A. Steinharter. John A. Steinharter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McNeish, Brendan, Kim Dittus, John A. Steinharter, et al.. (2024). The association of chemotherapy-induced peripheral neuropathy with reduced executive function in chemotherapy-treated cancer survivors: A cross-sectional study. Journal of Geriatric Oncology. 15(4). 101765–101765. 6 indexed citations
2.
McNeish, Brendan, Kim Dittus, John A. Steinharter, et al.. (2023). Executive function is associated with balance and falls in older cancer survivors treated with chemotherapy: A cross-sectional study. Journal of Geriatric Oncology. 14(8). 101637–101637. 9 indexed citations
3.
Wshah, Safwan, et al.. (2022). Classification of clinically relevant intravascular volume status using point of care ultrasound and machine learning. Journal of Medical Imaging. 9(5). 54502–54502.
4.
Doroshow, Deborah B., Andrew Schmidt, Ziad Bakouny, et al.. (2020). LBA74 Disparities in cancer during the COVID-19 pandemic: COVID-19 and cancer outcomes study (CCOS). Annals of Oncology. 31. S1204–S1204. 4 indexed citations
5.
McGregor, Bradley A., Aly‐Khan A. Lalani, Wanling Xie, et al.. (2020). Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma. European Journal of Cancer. 135. 203–210. 53 indexed citations
6.
Rubinstein, Samuel M., John A. Steinharter, Jeremy L. Warner, et al.. (2020). The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer. Cancer Cell. 37(6). 738–741. 30 indexed citations
7.
Alaiwi, Sarah Abou, Wanling Xie, Amin H. Nassar, et al.. (2020). Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 8(1). e000144–e000144. 64 indexed citations
8.
Pomerantz, Mark M., Kim Leitzel, Subrina Farah, et al.. (2020). Plasma IL-8 and PD-L1 and overall survival in metastatic castration-resistant prostate cancer patients (mCRPC).. Journal of Clinical Oncology. 38(15_suppl). e17565–e17565. 3 indexed citations
9.
10.
Lalani, Aly‐Khan A., Wanling Xie, David A. Braun, et al.. (2019). Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma. European Urology Oncology. 3(3). 372–381. 72 indexed citations
11.
Lalani, Aly‐Khan A., Ziad Bakouny, Subrina Farah, et al.. (2019). Efficacy of immune checkpoint inhibitors (ICI) and genomic alterations by body mass index (BMI) in advanced renal cell carcinoma (RCC). Annals of Oncology. 30. v396–v396. 4 indexed citations
12.
13.
Bakouny, Ziad, Natalie I. Vokes, Xīn Gào, et al.. (2019). Efficacy of immune checkpoint inhibitors (ICI) and genomic characterization of sarcomatoid and/or rhabdoid (S/R) metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 37(15_suppl). 4514–4514. 6 indexed citations
14.
Alaiwi, Sarah Abou, Dylan J. Martini, Wanling Xie, et al.. (2019). Safety and efficacy of restarting immune checkpoint inhibitors (CPI) after immune-related adverse events (irAEs) in metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 37(7_suppl). 652–652. 3 indexed citations
15.
McGregor, Bradley A., Rana R. McKay, David A. Braun, et al.. (2019). Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features. Journal of Clinical Oncology. 38(1). 63–70. 108 indexed citations
16.
Nuzzo, Pier Vitale, Sándor Spisák, Ankur Chakravarthy, et al.. (2019). Cell-free methylated DNA (cfMeDNA) immunoprecipitation and high throughput sequencing technology (cfMeDIP-seq) in patients with clear cell renal cell carcinoma (ccRCC).. Journal of Clinical Oncology. 37(15_suppl). 3052–3052. 2 indexed citations
17.
Lalani, Aly‐Khan A., Wanling Xie, Ronan Flippot, et al.. (2019). Impact of body mass index (BMI) on treatment outcomes to immune checkpoint blockade (ICB) in metastatic renal cell carcinoma (mRCC).. Journal of Clinical Oncology. 37(7_suppl). 566–566. 11 indexed citations
18.
Lalani, Aly‐Khan A., Wanling Xie, Dylan J. Martini, et al.. (2018). Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 6(1). 5–5. 197 indexed citations
19.
Lalani, Aly‐Khan A., Wanling Xie, Dylan J. Martini, et al.. (2017). Change in neutrophil-to-lymphocyte ratio (NLR) in response to immunotherapy for metastatic renal cell carcinoma (mRCC). Annals of Oncology. 28. v314–v315.
20.
Martini, Dylan J., Aly‐Khan A. Lalani, Dominick Bossé, et al.. (2017). Response to single agent PD-1 inhibitor after progression on previous PD-1/PD-L1 inhibitors: a case series. Journal for ImmunoTherapy of Cancer. 5(1). 66–66. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jae Young Joung Breakdown of academic impact, for papers by Milena Perez Mak Breakdown of academic impact, for papers by Huabin Hu Breakdown of academic impact, for papers by Melina E. Marmarelis Breakdown of academic impact, for papers by R. Corre Breakdown of academic impact, for papers by Julie Kobie Breakdown of academic impact, for papers by Yasser Ged Breakdown of academic impact, for papers by E. del Barco Breakdown of academic impact, for papers by Amaury Daste Breakdown of academic impact, for papers by Branka Čučević
Rankless by CCL
2026